Physician profile
Patrick A Titzer
NPI 1346657012
$10,934.31
in general payments reported to CMS, 2019-2025
59 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,897 · 2020: $1,925 · 2021: $2,381 · 2022: $854 · 2023: $1,528 · 2024: $1,132 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,877.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,346.90 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,016.26 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $989.51 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals Lp | $841.67 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $828.14 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $537.61 | 2020-2025 | Repatha, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $442.38 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $393.19 | 2019-2023 | |
| Paratek Pharmaceuticals, INC. | $304.83 | 2019-2023 | Nuzyra |
| Amarin Pharma, INC. | $274.50 | 2020-2021 | |
| Abbott Laboratories | $234.47 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.87 | 2019-2023 | Ofev, Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $214.34 | 2020-2023 | Gattex |
| Organogenesis INC. | $208.20 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $196.79 | 2019-2022 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Titzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.